

Sofinnova Venture Affiliates VI LP - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Sofinnova Venture Affiliates VI LP
Check out list of companies and businesses related to Sofinnova Venture Affiliates VI LP. Find out Sofinnova Venture Affiliates VI LP address and contact details. View other people related to Sofinnova Venture Affiliates VI LP - coworkers, colleagues, companions, etc.
Address:   

2800 SAND HILL ROAD, SUITE 150  MENLO PARK 94025 CA




Companies related to Sofinnova Venture Affiliates VI LP
CIKCompany NamePositionCompany Address0001267813MARINUS PHARMACEUTICALS INC170 N RADNOR CHESTER RD SUITE 250 RADNOR 190870001274644Ocera Therapeutics, Inc.555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY 940650001316175Anthera Pharmaceuticals Inc25801 INDUSTRIAL BOULEVARD, SUITE B  HAYWARD 94545




Sofinnova Venture Affiliates VI LP on the Web
Persons related to Sofinnova Venture Affiliates VI LP - MARINUS PHARMACEUTICALS INCNamePositionCityBARBER  ALANBRANFORDMEHRA  ANANDBRANFORDMehra, M.D.  AnandBranfordMehra, M.D.  AnandNew HavenGopka  AntonBranfordGopka  AntonNew HavenAlain  AzanSAN FRANCISCOAlain  AzanMENLO PARKJAMES C  BLAIRPRINCETONStephen M  BlochDirector WESTPORTStephen M  BlochNEW HAVENStephen M  BlochDirector WESTPORTEric  BuatoisSAN FRANCISCOEric  BuatoisMENLO PARKSTUART  CABLEBOSTONCanaan Partners VII LLCWESTFORDCanaan Partners VII LLCWESTPORTCanaan VII L P10% Owner WESTFORDCanaan VII L PDirector WESTPORTCanaan VII LPDirector WESTPORTEnrique J.  CarrazanaDirector HAWTHORNEEnrique J.  CarrazanaDirector NEW HAVENChristopher Michael  CashmanChairman and CEO NEW HAVENChristopher Michael  CashmanPRESIDENT AND CEO NEW HAVENChristopher Michael  CashmanPresident and CEO RADNORCashman  ChristopherBranfordCashman  ChristopherNew HavenASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONMICHAEL R  DOUGHERTYBRIAN H  DOVEYPRINCETONDP VI Associates, L.P.10% Owner PRINCETONGail M  FarfelChief Clinical Dev & Reg Offic NEW HAVENGail M  FarfelChief Clinical Dev & Reg RADNORSeth H.Z.  FischerDirector SAN DIEGOAnton  GopkaDirector NEW HAVENBrian K  HalakPRINCETONPENNER, JR.  HARRYBRANFORDPenner  HarryBranfordPenner  HarryNew HavenRein  HarryBranfordRein  HarryNew HavenJAMES  HEALYBRISBANEJAMES  HEALYMENLO PARKKRAYACICH  JOHNBRANFORDKim P.  KamdarPRINCETONSHAW  KENNETHBRANFORDMasuoka K.  LorianneSAN CARLOSTIMOTHY M  MAYLEBENDirector ANN ARBORTIMOTHY M  MAYLEBENDirector NEW HAVENAnand  Mehra10% Owner MENLO PARKAnand  MehraDirector MENLO PARKVitullo  NicoleNew HavenVITULLO  NICOLEBRANFORDAlbena  PatronevaChief Medical Officer RADNORMICHAEL  POWELLMICHAEL  POWELLMENLO PARKKATHLEEN K  SCHOEMAKERPRINCETONNimesh  ShahPRINCETONJay  ShepardDirector CUPERTINOJay  ShepardDirector NEW HAVENEdward F  SmithCFO PHILADELPHIAEdward F  SmithNEW HAVENEdward F  SmithCFO RADNORSofinnova Management VI, L.L.C.SAN FRANCISCOSofinnova Management VI, L.L.C.MENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSOFINNOVA VENTURE PARTNERS VI L PSAN FRANCISCOSOFINNOVA VENTURE PARTNERS VI L PMENLO PARKBLOCH  STEPHENBRANFORDBloch, M.D.  StephenBranfordBloch, M.D.  StephenNew HavenMayleben  TimothyNew HavenMAYLEBEN  TIMOTHYBRANFORDJESSE I  TREUPRINCETONNICOLE  VITULLODirector RICHMONDNICOLE  VITULLODirector PRINCETONPersons related to Sofinnova Venture Affiliates VI LP - Ocera Therapeutics, Inc.NamePositionCity14159 capital (GP), LLC10% Owner NEW YORKDavidson  AaronDurhamGEORGE B  ABERCROMBIEDirector DURHAMGEORGE B  ABERCROMBIEDirector DURHAMGaurav  AggarwalChief Business Officer SOUTH SAN FRANCISCOGaurav  AggarwalChief Business Officer PALO ALTOERIC  AGUIARSTAMFORDERIC  AGUIARMINNEAPOLISZisson  AlexDurhamVanLent  AnneSan DiegoVanLent  AnnePalo AltoAlain  AzanMENLO PARKBaker Biotech Capital (GP), LLC10% Owner NEW YORKBaker Brothers Life Sciences Capital (GP), LLC10% Owner NEW YORKFELIX  BAKERNEW YORKJULIAN  BAKERNEW YORKBDC CAPITAL INC.10% Owner MONTREAL, QUEBEC, CANADAJAMES C  BLAIR10% Owner PRINCETONGavin  BrendaDurhamEric  BuatoisMENLO PARKStan  BukofzerChief Medical Officer PALO ALTOMichael  ByrnesCFO and Treasurer PALO ALTOregional et cooperatif Desjardins  Capital10% Owner MONTREAL, QUEBEC, CANADAJean-Paul  CastaigneDirector DURHAMJean-Paul  CastaigneDirector DURHAMJean-Paul  CastaigneDirector PALO ALTOMcGowan  DanaSan DiegoDrutz  DavidDurhamMoore  DavidSan DiegoMoore  DavidPalo AltoAaron  DavidsonDirector DURHAMAaron  DavidsonMIAMIAaron  DavidsonDirector DURHAMWillard H  DereDirector THOUSAND OAKSS.E.C.  Desjardins-InnovatechMONTREAL, QUEBEC, CANADAASSOCIATES  DOMAINPRINCETONDomain Partners VI, L.P.10% Owner PRINCETONDomain Partners VIII, L.P.PRINCETONCorcoran  DonaldDurhamBRIAN H  DOVEY10% Owner PRINCETONDP VI Associates, L.P.PRINCETONDP VIII Associates, L.P.PRINCETONWeber  EckardPalo AltoWeber  EckardSan DiegoRichard I  EisenstadtVP, Finance & C.F.O. DURHAMRichard I  EisenstadtVP, Finance & CFO DURHAMLars  EkmanLA JOLLARousseau  FranckSan DiegoRousseau  FranckPalo AltoVipin K  GargPresident & C.E.O. DURHAMVipin K  GargPresident & CEO DURHAMBrenda D  GavinPHILADELPHIABrenda D  GavinDirector DURHAMLinda S  GraisPresident and CEO MENLO PARKLinda S  GraisPresident and CEO SAN DIEGOLinda S  GraisPresident and CEO PALO ALTOH.I.G. Ventures - Tranzyme, LLC10% Owner MIAMIBrian K  Halak10% Owner PRINCETONJAMES  HEALYMENLO PARKHIG GP II INCMIAMIJERYL L  HILLEMANSAN DIEGOJERYL L  HILLEMANCFO and Secretary PALO ALTOSTEVEN P  JAMESDirector Steven P  JamesDirector PALO ALTOCastaigne  Jean-PaulDurhamCastaigne  Jean-PaulSan DiegoCastaigne  Jean-PaulPalo AltoHilleman  JerylPalo AltoJOHN  JOHNSONDirector DURHAMJOHN  JOHNSONDirector DURHAMKim P.  KamdarPRINCETONNina S  KjellsonDirector MENLO PARKNina S  KjellsonDirector PALO ALTONina S  KjellsonDirector MENLO PARKNina S  KjellsonDirector MENLO PARKGordana  KosuticVP, Clinical and Regulatory DURHAMEkman  LarsSan DiegoEkman  LarsPalo AltoGrais  LindaSan DiegoGrais  LindaPalo AltoDana S.  McGowanCFO and Secretary SAN DIEGOPete  McNerneyMINNEAPOLISPete  McNerneyMINNEAPOLISPowell  MichaelSan DiegoPowell  MichaelPalo AltoSAMI  MNAYMNEHMIAMIDavid  MooreVP, Commercial Operations DURHAMDavid  MooreVP, Commercial Operations DURHAMKjellson  NinaSan DiegoKjellson  NinaPalo AltoRajiv  PatniChief Development Officer PALO ALTOMICHAEL  POWELLDirector MICHAEL  POWELLDirector MENLO PARKMICHAEL  POWELLDirector PALO ALTOShah  PratikSan DiegoShah  PratikPalo AltoQUAKER BIO VENTURES LP10% Owner PHILADELPHIAQUAKER BIOVENTURES CAPITAL LPPHILADELPHIAEisenstadt  RichardDurhamFRANCK  ROUSSEAUChief Medical Officer DURHAMFRANCK  ROUSSEAUChief Medical Officer DURHAMFRANCK  ROUSSEAUChief Medical & DEV Officer PALO ALTOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONNimesh  ShahPRINCETONPratik  ShahMINNEAPOLISPratik  ShahMINNEAPOLISPratik  ShahDirector PALO ALTOSofinnova Management VI, L.L.C.MENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSOFINNOVA VENTURE PARTNERS VI L P10% Owner MENLO PARKRhonda L.  StanleyDURHAMANTHONY  TAMERMIAMISHARON  TETLOWActing CFO & Treasurer PALO ALTOHelmut  ThomasSenior VP, R&D DURHAMHelmut  ThomasSenior VP, R&D DURHAMJAMES E  THOMASJAMES E  THOMASMINNEAPOLISJAMES E  THOMASMINNEAPOLISJAMES E  THOMASMINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II L.P.MINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISThomas, McNerney & Partners II, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISThomas, McNerney & Partners, LLCMINNEAPOLISTHOMAS MCNERNEY & PARTNERS LPMINNEAPOLISTHOMAS MCNERNEY & PARTNERS LP10% Owner MINNEAPOLISTHOMAS MCNERNEY & PARTNERS LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP Associates II LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP ASSOCIATES LPMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee II, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISTMP Nominee, LLCMINNEAPOLISJESSE I  TREU10% Owner PRINCETONANNE  VANLENTDirector PRINCETONANNE  VANLENTDURHAMANNE  VANLENTDirector DURHAMANNE  VANLENTDirector DURHAMANNE  VANLENTDirector PALO ALTOGarg  VipinDurhamNICOLE  VITULLO10% Owner PRINCETONECKARD  WEBERDirector SOUTH SAN FRANCISCOECKARD  WEBERSAN DIEGOECKARD  WEBERDirector SAN DIEGOECKARD  WEBERDirector PALO ALTOWENDALL  WIERENGADirector PALO ALTOWENDALL D  WIERENGADirector SAN DIEGOAlex  ZissonMINNEAPOLISAlex  ZissonDirector DURHAMAlex  ZissonDirector DURHAMAlex  ZissonMINNEAPOLISPersons related to Sofinnova Venture Affiliates VI LP - Anthera Pharmaceuticals IncNamePositionCityAlain  AzanMENLO PARKAlain  AzanMENLO PARKAnnette  BianchiDirector SAN BRUNOAnnette  BianchiSAN BRUNOEric  BuatoisMENLO PARKKlara  DickinsonChief Regulatory Officer SOUTH SAN FRANCISCOBOGDAN  DZIURZYNSKI HAYWARDBOGDAN  DZIURZYNSKIHAYWARDBOGDAN  DZIURZYNSKIDirector HAYWARDBOGDAN  DZIURZYNSKIDirector HAYWARDBOGDAN  DZIURZYNSKI HAYWARDSTEVEN B  ENGLE SAN DIEGOSTEVEN B  ENGLEBERKELEYSTEVEN B  ENGLE HAYWARDUrsula  FritschVP, Glob. Reg. & Compliance HAYWARDBrent  FursePARSIPPANYJAMES  HEALYDirector MENLO PARKJAMES  HEALY HAYWARDJAMES  HEALYDirector HAYWARDCHRISTOPHER S  HENNEY SEATTLECHRISTOPHER S  HENNEY HAYWARDCHRISTOPHER S  HENNEY HAYWARDCHRISTOPHER S  HENNEYDirector HAYWARDColin  HislopChief Medical Officer HAYWARDColin  HislopChief Medical Officer HAYWARDColin  HislopChief Medical Officer HAYWARDSAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKSAMUEL D  ISALYNEW YORKGEORGINA  KILFOILSVP, Prod. Dev. & Project Mngm HAYWARDGEORGINA  KILFOILSVP,Product Dev.& Project Mgmt HAYWARDGEORGINA  KILFOILSVP,Product Dev.& Project Mgmt HAYWARDStephen  LauVP, Corp. & Business Dev. HAYWARDA. Rachel  LehenyDirector HAYWARDMAY  LIUPrincipal Accounting Officer HAYWARDCHRISTOPHER P.  LOWEChief Financial Officer & CBO HAYWARDCHRISTOPHER P.  LOWEC.F.O. and C.B.O. HAYWARDCHRISTOPHER P.  LOWEC.F.O. and C.B.O. HAYWARDCHRISTOPHER P.  LOWECFO and Chief Business Officer HAYWARDBrian  Mueller NOVATOBrian  MuellerHAYWARDBrian  Mueller HAYWARDBrian  Mueller HAYWARDDEBRA  ODINKChief Technology Officer HAYWARDDEBRA  ODINKChief Technology Officer HAYWARDDEBRA  ODINKChief Technology Officer HAYWARDCharles V  OlsonChief Technology Officer HAYWARDORBIMED ADVISORS LLCDirector NEW YORKORBIMED ADVISORS LLCDirector NEW YORKORBIMED ADVISORS LLC10% Owner NEW YORKORBIMED ADVISORS LLCDirector NEW YORKOrbiMed Capital GP IV LLCNEW YORKOrbiMed Capital GP IV LLCNEW YORKOrbiMed Capital GP IV LLCNEW YORKJames  PenningtonHAYWARDJAMES E  PENNINGTONHAYWARDMICHAEL  POWELLMENLO PARKPhilip  Sager HAYWARDPhilip  Sager HAYWARDPhilip  Sager HAYWARDALAN E  SALZMANSAN BRUNOALAN E  SALZMANSAN BRUNODonald J  SantelDirector HAYWARDWILLIAM R  SHANAHAN JRChief Medical Officer SAN DIEGOSofinnova Management VI, L.L.C.SAN FRANCISCOSofinnova Management VI, L.L.C.10% Owner SAN FRANCISCOSofinnova Management VI, L.L.C.MENLO PARKSofinnova Venture Partners VI GmbH & Co. KGMENLO PARKSOFINNOVA VENTURE PARTNERS VI L P10% Owner SAN FRANCISCOSOFINNOVA VENTURE PARTNERS VI L P10% Owner MENLO PARKDANIEL K  SPIEGELMAN HAYWARDDANIEL K  SPIEGELMAN HAYWARDDANIEL K  SPIEGELMANDirector HAYWARDDavid E.  ThompsonDirector HAYWARDDavid E.  Thompson HAYWARDDavid E.  Thompson HAYWARDJOHN CRAIG  THOMPSONPresident & CEO SAN DIEGOPeter A.  ThompsonDirector HAYWARDJoaquim  TriasSr. VP, Preclinical Developmen HAYWARDPAUL F  TRUEXExecutive Chaiman HAYWARDPAUL F  TRUEXPresident and CEO HAYWARDPAUL F  TRUEXPresident and CEO HAYWARDPAUL F  TRUEXPresident and CEO HAYWARDPAUL F  TRUEXPresident and CEO HAYWARDVANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner SAN BRUNOVANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner SAN BRUNOVANTAGEPOINT VENTURE PARTNERS IV LPSAN BRUNOVANTAGEPOINT VENTURE PARTNERS IV LPSAN BRUNOVANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS  FUND LPSAN BRUNOVANTAGEPOINT VENTURE PARTNERS IV PRINCIPALS FUND LPSAN BRUNOVANTAGEPOINT VENTURE PARTNERS IV Q LPSAN BRUNOVANTAGEPOINT VENTURE PARTNERS IV Q LPSAN BRUNOZenyaku Kogyo Co., Ltd.TOKYOSANFORD S  ZWEIFACH HAYWARDSANFORD S  ZWEIFACH HAYWARDSANFORD S  ZWEIFACH HAYWARD
Potentially same personNameCityCountrySofinnova Venture Affiliates VI LPMENLO PARKCA












 








Sofinnova Venture Partners VI, L.P.: Private Company Information - Bloomberg









































  





















































































July 23, 2017 7:37 PM ET
Capital Markets

Company Overview of Sofinnova Venture Partners VI, L.P.



Snapshot People




Company Overview
Sofinnova Venture Partners specializes in venture capital investments in early stage information technology and life sciences companies. It invests in infrastructure for Internet and telecommunications, digital media, and product-oriented life sciences. The fund typically focuses on seed-stage and first institutional round investments, but it occasionally invests in intermediate and later-stage startup companies. It seeks to invest 85 per cent of its capital in the United States, with the remaining 15 per cent invested in European developed markets. The fund’s IT investing is heavily focused on the San Francisco Bay Area, while the Life Science investments covers San Diego, San Francisco, an...
Sofinnova Venture Partners specializes in venture capital investments in early stage information technology and life sciences companies. It invests in infrastructure for Internet and telecommunications, digital media, and product-oriented life sciences. The fund typically focuses on seed-stage and first institutional round investments, but it occasionally invests in intermediate and later-stage startup companies. It seeks to invest 85 per cent of its capital in the United States, with the remaining 15 per cent invested in European developed markets. The fund’s IT investing is heavily focused on the San Francisco Bay Area, while the Life Science investments covers San Diego, San Francisco, and Seattle. It typically invests between $8 million and $9 million in each company. 
Detailed Description


3000 Sand Hill RoadBuilding 4Suite 250Menlo Park, CA 94025United StatesFounded in 2002



Phone: 650-681-8420

Fax: 650-322-2037








Key Executives for Sofinnova Venture Partners VI, L.P.




Dr. James I. Healy M.D., Ph.D.


      	General Partner, Managing Partner, and Partner
      


Age: 52
        







Mr. Alain L. Azan


      	Founding Partner
      








Dr. Michael F. Powell Ph.D.


      	General Partner and Managing General Partner 
      


Age: 62
        




Compensation as of Fiscal Year 2017. 



Similar Private Companies By Industry



Company Name
Region



 @Visory LLC United States 1 Road Partners LLC United States 11T Partners, LLC United States 123Jump.com, Inc. United States 1509225 Ontario, Inc. United States




Recent Private Companies Transactions



TypeDate
Target



No transactions available in the past 12 months.




Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Sofinnova Venture Partners VI, L.P., please visit --.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























Sofinnova Ventures













Home
Team
Portfolio
About
News
Contact
HealthQuest Capital
Sofinnova Partners
Investor Portal




Partners for Development Equity in Biotech





Sofinnova Ventures News

September 14, 2017 Heather Behanna to speak at World Anti-Microbial Resistance Congress 2017
May 30, 2017 Sofinnova Announces the Addition of Industry Leader Alan Colowick, MD, MPH to its Partnership
April 11, 2017 Jim Healy to Speak at Cancer Advance Boston
February 06, 2017 Charlotte Shropshire to Speak at SuperReturn US West
October 24, 2016 Sofinnova Steps Up
October 17, 2016 Sofinnova Raises $650 Million for Oversubscribed Fund X
June 09, 2016 Jim Healy to Speak at BIO on Market & Political Pressures



Portfolio News

June 15, 2017 Art Krieg comes down from the mountain with a $27M round for Checkmate Pharmaceuticals
March 28, 2017 Virtual biotech Antiva sets out on a big R&D quest, armed with a $22M round for an HPV therapy
March 22, 2017 BioClin Therapeutics, Inc., Raises $30 Million in Series B Financing Led by Sofinnova Ventures and Ysios Capital
January 25, 2017 ObsEva SA Announces Pricing of Initial Public Offering
January 17, 2017 ObsEva Expands Leadership Team and Board of Directors with Industry Veterans
December 19, 2016 Novartis bolsters innovative dermatology portfolio through
acquisition of Ziarco Group Limited
November 28, 2016 Galera Therapeutics Receives $15M from Sofinnova Ventures
November 28, 2016 Galera Therapeutics Expands Series B to $57 Million



Contact
Menlo Park
3000 Sand Hill Road, Building 4, Suite 250
Menlo Park, CA 94025
Telephone (650) 681-8428
San Diego
1250 Prospect Street, Ocean Level - 4
La Jolla, CA 92037
Telephone (858) 551-4880
For inquiries please email: info@sofinnova.com
For information about our sister firm Sofinnova Partners based in Paris, France, please visit www.sofinnova.fr. 

© 2016 Sofinnova Ventures, Inc.












SOFINNOVA VENTURE AFFILIATES VI LP Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      SOFINNOVA VENTURE AFFILIATES VI LP
                    

•   MENLO PARK, CA
                      
How do I update this listing?




                                             Sofinnova Venture Affiliates VI is based out of Menlo Park.   
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from SOFINNOVA VENTURE AFFILIATES VI LP, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




sofinnova venture affiliates vi lp


3000 SAND HILL ROAD, 4-250

MENLO PARK
CA
                                                        
                                                    94025


                                                      Business Phone:
                                                      (650) 681-8420







Recent SEC Filings




4 filed on 10/24/2016
4 filed on 08/07/2014
3 filed on 07/31/2014
4 filed on 03/20/2014
4 filed on 07/17/2013
3 filed on 07/17/2013
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




















403 - Forbidden: Access is denied.



Server Error


403 - Forbidden: Access is denied.
You do not have permission to view this directory or page using the credentials that you supplied.






Sofinnova Venture Partners VIII, L.P., BizPedia.xyz - We monitor changes in companies





















BizPedia.xyz  - We monitor changes in companies
 






Sofinnova Venture Partners VIII, L.P.


FREE EMAIL WATCHDOG
Get free email notifications about news in Sofinnova Venture Partners VIII, L.P..










The service is free and you can unsubscribe at any time.

General | People (3) | Filings (36) | Investment rounds (2)
CIK Number: 0001524064Sofinnova Venture Partners VIII, L.P. is on the market less than 5 years.

Sofinnova Venture Partners VIII, L.P. address3000 SAND HILL ROAD, 4-250MENLO PARK 94025
Company jurisdiction
DELAWARE  
  Entity type
Limited Partnership 
Earliest known filing
July 2011
Latest known filing
April 2017




Company filings
SEC filings are a great source of information for companies including investments, company events, and all sorts of other information. 
Sofinnova Venture Partners VIII, L.P. has 36 filings. View Sofinnova Venture Partners VIII, L.P. filings.
Investment RoundsSofinnova Venture Partners VIII, L.P. recieved 2 investments.
PeopleWe have found 3 people related to Sofinnova Venture Partners VIII, L.P..
Similar companiesSofinnova Ventures Inc, SOFINNOVA VENTURE PRINCIPALS V LP, Sofinnova Venture Partners X, L.P., SOFINNOVA VENTURE PARTNERS VII L P, SOFINNOVA VENTURE PARTNERS VI L P, Sofinnova Venture Partners VI GmbH & Co. KG, SOFINNOVA VENTURE PARTNERS V LP, Sofinnova Venture Partners IX, L.P., SOFINNOVA VENTURE PARTNERS IV L P, Sofinnova Venture Affiliates VI LP, SOFINNOVA VENTURE AFFILIATES V LP, Sofinnova Partners SAS, Sofinnova Management VIII, L.L.C., Sofinnova Management VII, L.L.C., Sofinnova Management VI, L.L.C., Sofinnova Management VI, L.L.C., Sofinnova Management V LLC, Sofinnova Management V 2005, LLC, Sofinnova Management IX, L.L.C., Sofinnova HealthQuest Partners, L.P., Sofinnova Capital VII FCPR, SOFINNOVA CAPITAL VI FCPR, Sofinnova Capital V FCPR, Sofinnova Capital IV FCPR, Sofinnova Capital II FCPR, Sofinnova BioEquities, LP














BizPedia.xyz collect news, financial information, SEC filings, stock information, contact information, personal information, information about investments, etc. about Sofinnova Venture Partners VIII, L.P.. 








 SECGems: Sofinnova Venture Partners VI GmbH & Co. KG 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 Sofinnova Venture Partners VI GmbH & Co. KG 
		     










 Info




 Ownership




 Filings
10













	 
	
	 3000 SAND HILL ROAD, 4-250
	 
	
	
	   MENLO PARK, 
	   CA, 
	  
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	   (650) 681-8420    
	    

						        









Filing DateCurrent and former namesChanged on date




2011-12-22Sofinnova Venture Partners VI GmbH & Co. KG








Central Index Key (CIK)
0001397189
State of Incorporation
2M
Country of Incorporation
GERMANY
Fiscal year end
1231










Ownership (Form 3,4,5)# Filings





 Azan Alain (0001294340) 


10




 Buatois Eric (0001362314) 


10




 HEALY JAMES (0001245624) 


8




 Mehra Anand (0001590102) 


3




 POWELL MICHAEL (0001202793) 


7




 SOFINNOVA VENTURE PARTNERS VI L P (0001211465) 


10




 Sofinnova Management VI LLC (0001397188) 


10




 Sofinnova Venture Affiliates VI LP (0001312272) 


10











All related persons/companies# Filings





 Anthera Pharmaceuticals Inc (0001316175) 


4




 Azan Alain (0001294340) 


10




 Buatois Eric (0001362314) 


10




 HEALY JAMES (0001245624) 


8




 MARINUS PHARMACEUTICALS INC (0001267813) 


3




 Mehra Anand (0001590102) 


3




 Ocera Therapeutics, Inc. (0001274644) 


3




 POWELL MICHAEL (0001202793) 


7




 SOFINNOVA VENTURE PARTNERS VI L P (0001211465) 


10




 Sofinnova Management VI, L.L.C. (0001397188) 


10




 Sofinnova Venture Affiliates VI LP (0001312272) 


10




 TRANZYME INC


3







 








db
 
 










































SOFINNOVA VENTURE AFFILIATES V LP - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











SOFINNOVA VENTURE AFFILIATES V LP
Check out list of companies and businesses related to SOFINNOVA VENTURE AFFILIATES V LP. Find out SOFINNOVA VENTURE AFFILIATES V LP address and contact details. View other people related to SOFINNOVA VENTURE AFFILIATES V LP - coworkers, colleagues, companions, etc.
Address:   

140 GEARY STREET TENTH FLOOR  SAN FRANCISCO 94108 CA




Companies related to SOFINNOVA VENTURE AFFILIATES V LP
CIKCompany NamePositionCompany Address0001178711Paratek Pharmaceuticals, Inc.75 PARK PLAZA 4TH FLOOR BOSTON 02116




SOFINNOVA VENTURE AFFILIATES V LP on the Web
Persons related to SOFINNOVA VENTURE AFFILIATES V LP - Paratek Pharmaceuticals, Inc.NamePositionCitySRINIVAS  AKKARAJUMENLO PARKSRINIVAS  AKKARAJUMENLO PARKEDWARD C  ALBINIV.P., Chief Financial Officer SOUTH SAN FRANCISCOEDWARD C  ALBINIV.P., Chief Financial Officer SOUTH SAN FRANCISCOEDWARD C  ALBINIV.P., Chief Financial Officer SOUTH SAN FRANCISCOIvy  AngV.P., Human Resources SOUTH SAN FRANCISCOBRIAN G  ATWOODMENLO PARKAlain  AzanSAN FRANCISCOM JAMES  BARRETT10% Owner BALTIMOREPETER J  BARRIS10% Owner BALTIMOREMICHAEL  BIGHAMChairman and CEO MENLO PARKMICHAEL  BIGHAMChairman and CEO BOSTONJAMES C  BLAIR10% Owner PRINCETONJAMES C  BLAIRDirector PRINCETONBradley J PhD  BolzonMENLO PARKKathryn M.  BoxmeyerSee Remarks BOSTONDANIEL  BRADBURYDirector SOUTH SAN FRANCISCODANIEL  BRADBURYDirector SOUTH SAN FRANCISCOHARVEY B  CASHMENLO PARKPHILIPPE  CHAMBONNEW YORKPhilippe O.  ChambonNEW YORKBRUCE A  CLEVELANDMENLO PARKFong Wang  ClowSenior V.P., Development SOUTH SAN FRANCISCOSAMUEL D  COLELLAMENLO PARKJohn G  CurdPresident, CMO SOUTH SAN FRANCISCOBioVenture General Partner ApS  DanishCOPENHAGEN, DENMARKJeani  DelagardelleMENLO PARKJeani  DelagardelleMENLO PARKThomas John  DietzDirector PT. RICHMONDThomas John  DietzDirector BOSTONASSOCIATES  DOMAINPRINCETONDOMAIN PARTNERS V LP10% Owner PRINCETONBRIAN H  DOVEYPRINCETONBRIAN H  DOVEY10% Owner PRINCETONDP V ASSOCIATES LP10% Owner PRINCETONChristopher B  EhrlichDirector POINT RICHMONDChristopher B  EhrlichDirector POINT RICHMONDTimothy R  FransonDirector SALT LAKE CITYPHILIP T  GIANOSMENLO PARKBrian K  HalakPRINCETONWilliam M.  HaskelSr. VP, Sec. & General Counsel EAST RUTHERFORDHBM BIOVENTURES CAYMAN LTD10% Owner GRAND CAYMANHBM Healthcare Investments (Cayman) Ltd.GRAND CAYMANJAMES  HEALYDirector SAN FRANCISCOJUDITH A  HEMBERGERDirector SOUTH SAN FRANCISCOJUDITH A  HEMBERGERSOUTH SAN FRANCISCOW Stephen  HolmesMENLO PARKRONALD  HUNTNEW YORKRONALD  HUNTNEW YORKInterWest Management Partners IX, LLC10% Owner MENLO PARKInterWest Partners IX, LP10% Owner MENLO PARKROSS A MD  JAFFEMENLO PARKROSS A MD  JAFFEMENLO PARKDanish BioVenture  K/SCOPENHAGEN, DENMARKJoseph T  KennedyVP and General Counsel POINT RICHMONDJoseph T  KennedyVP and General Counsel POINT RICHMONDTHOMAS  KILEYDirector POINT RICHMONDTHOMAS  KILEYDirector POINT RICHMONDNina S  KjellsonMENLO PARKGilbert H  KlimanMENLO PARKJohn A  KollinsSVP, Chief Business Officer POINT RICHMONDSusan  KoppyVP, Corporate Development POINT RICHMONDC RICHARD  KRAMLICH10% Owner BALTIMOREKATHLEEN  LAPORTEDirector POINT RICHMONDKATHLEEN  LAPORTEDirector POINT RICHMONDKATHLEEN  LAPORTEDirector MENLO PARKKATHLEEN  LAPORTEMENLO PARKVijay K  LathiMENLO PARKVijay K  LathiMENLO PARKRichard J.  LimDirector BOSTONWILLIAM J PHD  LINKMENLO PARKMATTHEW M  LOARDirector RICHMONDEvan  LohPresident, COO and CMO BOSTONBARBARA N  LUBASHMENLO PARKDONALD B  MILDERMENLO PARKTerrence O  MooreVP, Marketing and Sales POINT RICHMONDTerrence O  MooreVP, Marketing and Sales POINT RICHMONDJay  MoorinDirector PRINCETONJay  MoorinDirector PRINCETONROBERT J  MORE10% Owner PRINCETONPETER  MORRIS10% Owner BALTIMORKHALED  NASRMENLO PARKNEA PARTNERS 10 L P10% Owner BALTIMORENEW ENTERPRISE ASSOCIATES 10 L P10% Owner BALTIMORENew Leaf Venture Management I, L.L.C.NEW YORKNew Leaf Venture Management I, L.L.C.NEW YORKNew Leaf Venture Management I, L.P.NEW YORKNew Leaf Venture Management I, L.P.NEW YORKNew Leaf Ventures I, L.P.NEW YORKNew Leaf Ventures I, L.P.10% Owner NEW YORKCHARLES W  NEWHALL III10% Owner BALTIMOREJAMES  NIEDELNEW YORKJAMES  NIEDELNEW YORKJason Raleigh  NunnBALTIMOREJason Raleigh  NunnDirector TIMONIUMGLENN A  OCLASSENPresident and CEO POINT RICHMONDGLENN A  OCLASSENPresident and CEO POINT RICHMONDOmega Fund III G.P., Ltd.GUERNSEY, CHANNEL ISLANDS, UKOmega Fund III GP, L.P.GUERNSEY, CHANNEL ISLANDS, UKOmega Fund III, L.P.10% Owner GUERNSEY, CHANNEL ISLANDSOmega Fund III, L.P.GUERNSEY, CHANNEL ISLANDS, UKOmega Fund IV G.P. Manager, Ltd.GUERNSEY, CHANNEL ISLANDS, UKOmega Fund IV GP, L.P.GUERNSEY, CHANNEL ISLANDS, UKOmega Fund IV, L.P.ST. PETER PORTOmega Fund IV, L.P.GUERNSEY, CHANNEL ISLANDS, UKOmega Fund Management LTDGUERNSEY, CHANNEL ISLANDS, UKARNOLD L  ORONSKYMENLO PARKDouglas W.  PaganChief Financial Officer BOSTONLEONE D  PATTERSONVice President, CFO PT. RICHMONDDouglas A  PepperMENLO PARKMARK W  PERRY10% Owner BALTIMOREKristine  PetersonDirector MYSTICMICHAEL  POWELLSAN FRANCISCOG KIRK  RAABPOINT RICHMONDG KIRK  RAABDirector POINT RICHMONDG KIRK  RAABDirector POINT RICHMONDMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABBALTIMORERobert S  RadieDirector WAYNERobert S  RadieDirector BOSTONREBECCA B  ROBERTSON10% Owner MENLO PARKThomas L  RoschMENLO PARKRoumell Asset Management, LLC10% Owner CHEVY CHASEFrederick J  RuegseggerDirector SOUTH SAN FRANCISCOFrederick J  RuegseggerDirector POINT RICHMONDFrederick J  RuegseggerDirector POINT RICHMONDCamille D  SamuelsDirector MENLO PARKCamille D  SamuelsMENLO PARKCamille D  SamuelsDirector POINT RICHMONDCamille D  SamuelsDirector POINT RICHMONDSCOTT D  SANDELL10% Owner BALTIMOREEdward F.  SchnipperSOUTH SAN FRANCISCOKATHLEEN K  SCHOEMAKER10% Owner PRINCETONLOWELL  SEARSDirector SOUTH SAN FRANCISCOLOWELL  SEARSDirector SOUTH SAN FRANCISCOLOWELL  SEARSDirector SOUTH SAN FRANCISCOSigma Holding LTDGUERNSEY, CHANNEL ISLANDS, UKAmar P  SinghChf. Commercialization Officer SOUTH SAN FRANCISCOAmar P  SinghChf. Commercialization Officer SOUTH SAN FRANCISCOAmar P  SinghChf. Commercialization Officer SOUTH SAN FRANCISCONikhilesh N  SinghSVP & Chief Scientific Officer POINT RICHMONDNikhilesh N  SinghSVP & Chief Scientific Officer POINT RICHMONDSofinnova Management V LLCSAN FRANCISCOSOFINNOVA VENTURE PARTNERS V LPSAN FRANCISCOSOFINNOVA VENTURE PRINCIPALS V LPSAN FRANCISCOThomas P  SolowaySVP, Operations and CFO POINT RICHMONDThomas P  SolowayEVP, Chief Operating Officer POINT RICHMONDOtello  StampacchiaGUERNSEY, CHANNEL ISLANDS, UKJeffrey  SteinDirector SAN DIEGOJeffrey  SteinDirector BOSTONEUGENE A  TRAINOR III10% Owner BALTIMOREJESSE I  TREU10% Owner PRINCETONJESSE I  TREU10% Owner PRINCETONDANIEL K  TURNER IIIDirector POINT RICHMONDDANIEL K  TURNER IIIDirector POINT RICHMONDVersant Affiliates Fund II-A, LPMENLO PARKVersant Side Fund II, LPMENLO PARKVersant Venture Capital II, LPMENLO PARKVersant Ventures II LLCMENLO PARKNICOLE  VITULLOPRINCETONJOHN PETER  WALKERChief Executive Officer SOUTH SAN FRANCISCOJOHN PETER  WALKERDirector POINT RICHMONDJOHN PETER  WALKERDirector POINT RICHMONDJOHN PETER  WALKERChief Executive Officer SOUTH SAN FRANCISCOJOHN PETER  WALKERDirector SOUTH SAN FRANCISCOCharles M  WardenMENLO PARKECKARD  WEBERDirector SOUTH SAN FRANCISCOECKARD  WEBERDirector SOUTH SAN FRANCISCOAdam  WoodrowVP & Chief Commercial Officer BOSTONMARILYN E  WORTZMANVP, Finance POINT RICHMONDMARILYN E  WORTZMANVP, Finance POINT RICHMOND
Potentially same personNameCityCountrySOFINNOVA VENTURE AFFILIATES V LPSAN FRANCISCOCASOFINNOVA VENTURE AFFILIATES V LPSAN FRANCISCOCASOFINNOVA VENTURE AFFILIATES V LPCASOFINNOVA VENTURE AFFILIATES V LPMENLO PARKCA












 









Insider Trading - Mehra Anand - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Mehra Anand





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-12-15Sale
2016-12-199:03 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
349,656
$53.46
$18,691,892
1,184,714(Indirect)
View


2016-12-09Sale
2016-12-137:25 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
122,532
$55.17
$6,759,555
1,368,274(Indirect)
View


2016-10-20Sale
2016-10-244:49 pm
Marinus Pharmaceuticals Inc
MRNS
Mehra AnandSofinnova Venture Partners Vi L PSofinnova Venture Partners Vi Gmbh & Co. KgSofinnova Venture Affiliates Vi LpSofinnova Management Vi L.L.C.Buatois EricHealy JamesAzan AlainPowell Michael10% Owner
750,683
$1.389
$1,042,699
1,134,851(Indirect)
View


2016-08-10Sale
2016-08-124:30 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
29,963
$60.13
$1,801,817
1,400,237(Indirect)
View


2016-08-08Sale
2016-08-107:13 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
100
$60.47
$6,047
1,407,137(Indirect)
View


2016-08-03Sale
2016-08-057:30 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
5,064
$60
$303,840
1,407,689(Indirect)
View


2016-08-01Sale
2016-08-036:27 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
22,665
$60.03
$1,360,580
1,412,301(Indirect)
View


2016-05-31Sale
2016-06-023:24 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
500
$60
$30,000
1,434,966(Indirect)
View


2015-11-25Sale
2015-11-307:38 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
22,961
$60.01
$1,377,943
1,440,816(Indirect)
View


2015-11-09Sale
2015-11-128:25 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
130,605
$60.11
$7,850,870
1,563,077(Indirect)
View


2015-10-13Purchase
2015-10-131:26 pm
Aclaris Therapeutics Inc.
ACRS
Mehra AnandDirector10% Owner
409,090
$11
$4,499,990
2,289,480(Indirect)
View


2015-10-07Sale
2015-10-097:59 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
529,544
$45.46
$24,074,435
2,033,074(Indirect)
View


2015-10-05Purchase
2015-10-064:09 pm
Mirna Therapeutics Inc.
MIRN
Sofinnova Venture Partners Viii L.P.Sofinnova Management Viii L.L.C.Healy JamesAkkaraju SrinivasMehra Anand10% Owner
857,142
$7
$5,999,994
2,974,811(Direct)
View


2015-05-12Purchase
2015-05-149:19 pm
Atyr Pharma Inc
LIFE
Sofinnova Venture Partners Ix L.P.Sofinnova Management Ix L.L.C.Healy JamesPowell MichaelMehra Anand10% Owner
320,000
$14
$4,480,000
1,866,126(Direct)
View


2015-04-14Sale
2015-04-167:23 pm
Aerie Pharmaceuticals Inc
AERI
Mehra AnandDirector
425,000
$33.64
$14,297,765
916,657(Indirect)
View


2015-02-04Purchase
2015-02-068:06 pm
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
225,000
$23
$5,175,000
2,118,576(Indirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-08-03Option Award
2016-08-057:32 pm
N/A2026-08-03
Marinus Pharmaceuticals Inc
MRNS
Mehra AnandDirector
7,700
$1.5
7,700(Direct)
View


2016-08-03Option Award
2016-08-057:32 pm
N/A2026-08-03
Marinus Pharmaceuticals Inc
MRNS
Mehra AnandDirector
3,300
$0
7,700(Direct)
View


2016-06-29Option Award
2016-07-014:16 pm
N/A2026-06-28
Aclaris Therapeutics Inc.
ACRS
Mehra AnandDirector10% Owner
6,632
$18.32
6,632(Direct)
View


2016-06-01Option Award
2016-06-034:32 pm
N/A2026-05-31
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
6,000
$56.22
6,000(Direct)
View


2015-10-13Conversion
2015-10-131:26 pm
N/AN/A
Aclaris Therapeutics Inc.
ACRS
Mehra AnandDirector10% Owner
1,880,390
$0
2,289,480(Indirect)
View


2015-10-13Conversion
2015-10-131:26 pm
N/AN/A
Aclaris Therapeutics Inc.
ACRS
Mehra AnandDirector10% Owner
2,000,000
$0
2,289,480(Indirect)
View


2015-10-13Conversion
2015-10-131:26 pm
N/AN/A
Aclaris Therapeutics Inc.
ACRS
Mehra AnandDirector10% Owner
2,424,242
$0
2,289,480(Indirect)
View


2015-10-13Conversion
2015-10-131:26 pm
N/AN/A
Aclaris Therapeutics Inc.
ACRS
Mehra AnandDirector10% Owner
2,063,107
$0
2,289,480(Indirect)
View


2015-10-05Conversion
2015-10-064:09 pm
N/AN/A
Mirna Therapeutics Inc.
MIRN
Sofinnova Venture Partners Viii L.P.Sofinnova Management Viii L.L.C.Healy JamesAkkaraju SrinivasMehra Anand10% Owner
1,244,269
$0
2,974,811(Direct)
View


2015-10-05Conversion
2015-10-064:09 pm
N/AN/A
Mirna Therapeutics Inc.
MIRN
Sofinnova Venture Partners Viii L.P.Sofinnova Management Viii L.L.C.Healy JamesAkkaraju SrinivasMehra Anand10% Owner
583,559
$0
2,974,811(Direct)
View


2015-10-05Other
2015-10-064:09 pm
N/AN/A
Mirna Therapeutics Inc.
MIRN
Sofinnova Venture Partners Viii L.P.Sofinnova Management Viii L.L.C.Healy JamesAkkaraju SrinivasMehra Anand10% Owner
289,841
$0
2,974,811(Direct)
View


2015-10-05Conversion
2015-10-064:09 pm
N/AN/A
Mirna Therapeutics Inc.
MIRN
Sofinnova Venture Partners Viii L.P.Sofinnova Management Viii L.L.C.Healy JamesAkkaraju SrinivasMehra Anand10% Owner
1,244,269
$0
2,974,811(Direct)
View


2015-10-05Conversion
2015-10-064:09 pm
N/AN/A
Mirna Therapeutics Inc.
MIRN
Sofinnova Venture Partners Viii L.P.Sofinnova Management Viii L.L.C.Healy JamesAkkaraju SrinivasMehra Anand10% Owner
583,559
$0
2,974,811(Direct)
View


2015-07-20Option Award
2015-07-228:57 pm
N/A2025-07-20
Marinus Pharmaceuticals Inc
MRNS
Mehra AnandDirector10% Owner
6,300
$14.3
6,300(Direct)
View


2015-05-12Conversion
2015-05-149:19 pm
N/AN/A
Atyr Pharma Inc
LIFE
Sofinnova Venture Partners Ix L.P.Sofinnova Management Ix L.L.C.Healy JamesPowell MichaelMehra Anand10% Owner
1,546,126
$0
1,866,126(Direct)
View


2015-05-12Conversion
2015-05-149:19 pm
N/AN/A
Atyr Pharma Inc
LIFE
Sofinnova Venture Partners Ix L.P.Sofinnova Management Ix L.L.C.Healy JamesPowell MichaelMehra Anand10% Owner
14,968,722
$0
1,866,126(Direct)
View


2015-04-14Exercise
2015-04-167:23 pm
N/AN/A
Aerie Pharmaceuticals Inc
AERI
Mehra AnandDirector
150,000
$5
916,657(Indirect)
View


2015-04-14Other
2015-04-167:23 pm
N/AN/A
Aerie Pharmaceuticals Inc
AERI
Mehra AnandDirector
22,066
$5
916,657(Indirect)
View


2015-04-14Exercise
2015-04-167:23 pm
N/AN/A
Aerie Pharmaceuticals Inc
AERI
Mehra AnandDirector
150,000
$5
916,657(Indirect)
View


2015-04-10Option Award
2015-04-146:51 pm
N/AN/A
Aerie Pharmaceuticals Inc
AERI
Mehra AnandDirector
1,700
$0
766,657(Direct)
View


2015-04-10Option Award
2015-04-146:51 pm
N/A2025-04-10
Aerie Pharmaceuticals Inc
AERI
Mehra AnandDirector
10,000
$32.3
766,657(Direct)
View


2015-02-04Conversion
2015-02-068:06 pm
N/AN/A
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
1,893,576
$0
2,118,576(Indirect)
View


2015-02-04Option Award
2015-02-068:06 pm
N/AN/A
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
30,222
$0
2,118,576(Indirect)
View


2015-02-04Conversion
2015-02-068:06 pm
N/AN/A
Spark Therapeutics Inc.
ONCE
Mehra AnandDirector
1,893,576
$0
2,118,576(Indirect)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sun, 23 Jul 2017 18:37:25 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  
















































